Furthermore, KCNQ1OT1 was significantly increased in the plasma of patients with AIS, and its expression was positively correlated with the severity of stroke, which implied that KCNQ1OT1 may be a diagnostic biomarker or severity evaluation indicator. Here, KCNQ1OT1 is linked to androgen insensitivity syndrome.